Related Experiment Video

Updated: Jun 10, 2026

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade
09:50

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade

Published on: August 14, 2019

Synthesis and biological activity of flavanone derivatives

Lei Shi1, Xiu E Feng, Jing Rong Cui

  • 1School of Pharmaceutical Science, Shanxi Medical University, Taiyuan 030001, China.

Bioorganic & Medicinal Chemistry Letters
|August 17, 2010
PubMed

Insights

New flavanone derivatives of farrerol were synthesized and tested for pharmacological activity. Most compounds showed significant anti-tumor, protein tyrosine kinase (PTK) inhibitory, cytoprotective, and anti-atherosclerosis effects.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Organic Synthesis

Background:

  • Farrerol is a natural flavanone with known biological activities.
  • Developing novel synthetic derivatives can lead to improved pharmacological profiles.
  • Exploring structure-activity relationships is crucial for drug discovery.

Purpose of the Study:

  • To synthesize novel flavanone derivatives of farrerol.
  • To evaluate the in vitro anti-tumor, protein tyrosine kinase (PTK) inhibitory, cytoprotective, and anti-atherosclerosis activities of these derivatives.
  • To establish preliminary structure-activity relationships.

Main Methods:

  • Convenient synthetic methods were employed for derivative preparation.
  • In vitro assays included anti-tumor activity against Bel-7402, HL-60, BGC-823, and KB cell lines.
  • Protein tyrosine kinase (PTK) inhibition, cytoprotective effects against H2O2-induced injury, and anti-atherosclerosis activity were assessed.
  • Structural confirmation was performed using 1H, 13C NMR, and ESI-MS.

Main Results:

  • A series of new flavanone derivatives of farrerol were successfully synthesized.
  • Most synthesized compounds demonstrated significant in vitro pharmacological activities.
  • Preliminary structure-activity relationships were described, indicating potential for further optimization.

Conclusions:

  • The synthesized flavanone derivatives represent promising candidates for further investigation.
  • These compounds exhibit broad pharmacological potential, including anti-cancer and anti-atherosclerosis effects.
  • The study provides a foundation for designing more potent and selective flavanone-based therapeutics.

More Related Videos

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria06:38

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria

Published on: February 28, 2025

Green Synthesis, Characterization, Encapsulation, and Measurement of the Release Potential of Novel Alkali Lignin Micro-/Submicron Particles07:42

Green Synthesis, Characterization, Encapsulation, and Measurement of the Release Potential of Novel Alkali Lignin Micro-/Submicron Particles

Published on: March 1, 2024

Related Concept Videos

Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Local Anesthetics: Chemistry and Structure-Activity Relationship01:30

Local Anesthetics: Chemistry and Structure-Activity Relationship

Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...